Pharmafile Logo
Pharmafocus logo
Advanced Search
EMA's new look website

Digital Pharma: Byte-sized roundup

July 19, 2010
Medical Communications Amgen, Digital Pharma blog, EMA, Sermo, digital doctors, google, psoriasis

This week’s roundup includes EMA’s new look website, a psoriasis patient group’s e-commerce venture, Amgen’s online patient empowerment competition, changes …

News

NICE’s methods to be put under the spotlight

July 19, 2010
Sales and Marketing MRC, NICE, cost-effectiveness

The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …

News

US approval for Sanofi’s Jevtana

July 19, 2010
Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer

US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …

News

Elan expects Zonegran marketing probe to cost it $206m

July 19, 2010
Sales and Marketing Elan, Zonegran

Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …

News
Matthew_Speers

UCB’s Speers to lead European Medicines Group

July 19, 2010
Sales and Marketing European Medicines Group, UCB, appointment, sales and marketing

UCB Pharma’s managing director Matthew Speers has been elected chair of the European Medicines Group, taking over from Nigel Brooksby …

Appointment

NICE reaffirms positive opinion on Multaq

July 19, 2010
Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone

In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …

News

GSK takes £1.58bn hit from legal disputes

July 16, 2010
Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat

GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …

News

Lonza wins two biologic contracts

July 16, 2010
Manufacturing and Production Elusys, Human Genome Sciences, Lonza

Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …

News

UK pharma needs online pharmacovigilance guidance, says Digital Pioneer

July 16, 2010
Medical Communications Code of Practice, Sublime Digital, digital pharma

Pharma companies need more help from UK authorities on the issue of online pharmacovigilance, according to the winner of the …

News

Eisai collaborates on psychiatric disorder research

July 16, 2010
Research and Development Aestus Thereapeutics, Eisai

Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …

News

Changing business models top pharma concerns

July 16, 2010
Sales and Marketing Cegedim, industry, survey

The changing face of pharma business models is the main thing keeping US executives awake at night, according to a …

News

What might the NHS white paper mean for Pharma commercial models?

July 16, 2010
Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma

Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.

Feature
Thought Leadership

Promotions at ScopeMedical

July 16, 2010
Medical Communications ScopeMedical, appointment, medical communications

Kent, UK-based medical communications agency ScopeMedical has promoted a number of its team.They are: Sophie Smith (who moves to account …

Appointment

Olivier Bohuon joins Pierre Fabre

July 16, 2010
Sales and Marketing Abbott, Pierre Fabre, appointment, sales and marketing

Olivier Bohuon is to replace Jean-Pierre Garnier as the head of French pharma company Pierre Fabre from September. Bohuon is …

Appointment

Best GPs will outperform PCTs, says PCT leader

July 15, 2010
Sales and Marketing NHS, commissioning

The leader of the PCT managers’ organisation David Stout and Mark Britnell, the architect of the former Labour government’s commissioning …

News

Semi-synthetic shortcut could boost supply of antimalarial

July 15, 2010
Manufacturing and Production malaria

US researchers are pushing forward with the development of a cheaper, semi-synthetic version of artemisinin, the basis of the most …

News

New products spur Novartis growth

July 15, 2010
Sales and Marketing Novartis, Tasigna

Novartis has posted strong results for the second quarter of the year. The Swiss pharma company posted an 11% rise …

News

Pfizer form liver cancer research partnership in Korea

July 15, 2010
Research and Development

 Pfizer has formed a research partnership with Samsung Medical Centre in Seoul for the analysis of Korean liver cancer patients …

News
john-beighton

Goldshield appoints John Beighton

July 15, 2010
Sales and Marketing Goldshield, appointment, sales and marketing

UK generics company Goldshield has appointed John Beighton as chief executive. Beighton was formerly UK managing director of Teva, and …

Appointment

Medea appoints NHS advisor

July 15, 2010
Medical Communications Medea, appointment, medical communications

PR agency Medea Communications has engaged the former chair of a major hospital drugs and therapeutics committee to act as …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026